Shop

Wall Street Journal details how a Vitarine Pharmaceuticals employee cracked open capsules of another company's blood-pressure drug, had the contents tested, and sent along the results to the FDA as if it were Vitarine's own new drug; finds Vitarine made millions of dollars after the FDA gave approval, although the FDA eventually discovered the con; finds the FDA has trouble uncovering all the drug switches attempted by generic drug companies.

This file is not available for digital download. IRE members may place an order by emailing rescntr@ire.org